Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro

Doroodgar , Delavari M, Doroodgar , Abbasi A, Taherian A, Doroodgar

Tamoxifen is an antagonist of the estrogen receptor and currently used for the treatment of breast cancer. The current treatment of cutaneous leishmaniasis with pentavalent antimony compounds is not satisfactory....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice

Solgi G, Kariminia , Abdi K, Darabi M, Ghareghozloo B

For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucantime. Groups of mice were challenged with 5 x 10(3) metacyclic promastigotes of L. major subcutaneously....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite

Sadeghi S, Seyed N, Etemadzadeh MH, Abediankenari S, Rafati S, Taheri T

Leishmaniasis is a worldwide uncontrolled parasitic disease due to the lack of effective drug and vaccine. To speed up effective drug development, we need powerful methods to rapidly assess drug...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-leishmanial Effects of Trinitroglycerin in BALB/C Mice Infected with Leishmania major via Nitric Oxide Pathway

Nahrevanian H, Najafzadeh M, Hajihosseini R, Nazem H, Farahmand , Zamani Z

This study investigated whether trinitroglycerine (TNG) as nitric oxide (NO) releasing agent had anti-leishmanial effects and mediated pathology in BALB/c mice infected with Leishmania major. Cutaneous leishmaniasis (CL), a zoonotic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr